相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of metabolic syndrome risk factors and MMP-2 genetic variations on circulating MMP-2 levels in childhood obesity
Vanessa A. Belo et al.
MOLECULAR BIOLOGY REPORTS (2013)
Visfatin/NAMPT: A Multifaceted Molecule with Diverse Roles in Physiology and Pathophysiology
Tuva B. Dahl et al.
ANNUAL REVIEW OF NUTRITION, VOL 32 (2012)
NAMPT (visfatin) and AKT1 genetic variants associate with myocardial infarction
Karin Leander et al.
CLINICA CHIMICA ACTA (2012)
Common Variants of IL6, LEPR, and PBEF1 Are Associated With Obesity in Indian Children
Rubina Tabassum et al.
DIABETES (2012)
Visfatin May Be a Novel Marker for Identifying Stages of Essential Hypertension in Advanced Age Patients
Fahri Gunes et al.
INTERNAL MEDICINE (2012)
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children
V. A. Belo et al.
INTERNATIONAL JOURNAL OF OBESITY (2012)
Serum Visfatin Levels, Adiposity and Glucose Metabolism in Obese Adolescents
Derya Taskesen et al.
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY (2012)
The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance
Jianjun Lan et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta-analysis and systemic review
Yu-Hung Chang et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Vascular Endothelial Growth Factor Haplotypes Associated with Childhood Obesity
Vanessa A. Belo et al.
DNA AND CELL BIOLOGY (2011)
Visfatin in juvenile obesity - the effect of obesity intervention and sex
Malgorzata Krzystek-Korpacka et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2011)
A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease
Lian-Sheng Wang et al.
MOLECULAR BIOLOGY REPORTS (2011)
Visfatin, glucose metabolism and vascular disease: a review of evidence
Pedro Saddi-Rosa et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Assessment of matrix metalloproteinase (MMP)-2, MMP-8, MMP-9, and their inhibitors, the tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in obese children and adolescents
Vanessa A. Belo et al.
CLINICAL BIOCHEMISTRY (2009)
Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans
Sheng Wen Liu et al.
CLINICAL ENDOCRINOLOGY (2009)
Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome
Magnhild L. Kolsgaard et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2009)
Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-κB activation in endothelial cells
Su-Ryun Kim et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2008)
Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis
Ming Zhong et al.
CLINICAL ENDOCRINOLOGY (2008)
Serum visfatin concentrations in obese adolescents and its correlation with age and high-density lipoprotein cholesterol
Hua Jin et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children
Shunsuke Araki et al.
OBESITY (2008)
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Raghu Adya et al.
CARDIOVASCULAR RESEARCH (2008)
Molecular characteristics of serum visfatin and differential detection by immunoassays
Antje Koerner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Nampt/PBEF/Visfatin regulates insulin secretion in β cells as a systemic NAD biosynthetic enzyme
Javier R. Revollo et al.
CELL METABOLISM (2007)
Plasma visfatin levels in patients with newly diagnosed and untreated type 2 diabetes mellitus and impaired glucose tolerance
Teoman Dogru et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2007)
Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis -: Possible role in inflammation and plaque destabilization
Tuva B. Dahl et al.
CIRCULATION (2007)
Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension
T. Dogru et al.
JOURNAL OF HUMAN HYPERTENSION (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Serum visfatin increases with progressive β-cell deterioration
Abel Lopez-Bermejo et al.
DIABETES (2006)
Common polymorphisms in the promoter of the visfatin gene (PBEF1) influence plasma insulin levels in a French-Canadian population
Swneke D. Bailey et al.
DIABETES (2006)
The adipokine visfatin is markedly elevated in obese children
Dominik G. Haider et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2006)
The release of the adipocytokine visfatin is regulated by glucose and insulin
D. G. Haider et al.
DIABETOLOGIA (2006)
Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding
DG Haider et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Macrophages in human visceral adipose tissue:: increased accumulation in obesity and a source of resistin and visfatin
CA Curat et al.
DIABETOLOGIA (2006)
Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus
MP Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Plasma visfatin concentrations and fat depot-specific mRNA expression in humans
J Berndt et al.
DIABETES (2005)
Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents
M Keskin et al.
PEDIATRICS (2005)
被撤回的出版物: Visfatin: A protein secreted by visceral fat that mimics the effects of insulin (Retracted article, see vol 318, pg 565, 2007)
A Fukuhara et al.
SCIENCE (2005)
Obesity and the metabolic syndrome in children and adolescents
R Weiss et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Prevalence of a metabolic syndrome phenotype in adolescents - Findings from the Third National Health and Nutrition Examination Survey, 1988-1994
S Cook et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2003)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
A new statistical method for haplotype reconstruction from population data
M Stephens et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
